Search research articles
Contact Us
Filters
Showing results (91-100 of 249) with videos related to
Page
of 25
Sort By:
Gynecologic Oncology
|
July 1, 1988
Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapy
M E van der Burg, F B Lammes, W L van Putten, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
July 4, 1997
Determination of the lactone and lactone plus carboxylate forms of 9-aminocamptothecin in human plasma by sensitive high-performance liquid chromatography with fluorescence detection
W J Loos, A Sparreboom, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma
A S Planting, R de Wit, M E van der Burg, et al.
Cancer Research
|
May 1, 1991
Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes
H J Lamers, J W Gratama, W L van Putten, et al.
British Journal of Haematology
|
October 1, 1994
High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia
H Burger, K Nooter, P Sonneveld, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1997
Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)
P H Hilkens, J Verweij, C J Vecht, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine
L C Pronk, A S Planting, R Oosterom, et al.
British Journal of Cancer
|
November 21, 1998
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients
R de Wit, W H Kruit, G Stoter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1992
Frequent administration of Dabis Maleate, a phase I study
J Verweij, A S Planting, M de Boer, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1996
The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary
A van der Gaast, J Verwij, A S Planting, et al.
Page
of 25
Search research articles
Search
Showing results (91-100 of 249) with videos related to
Sort By:
Page
of 25
Gynecologic Oncology
|
July 1, 1988
Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapy
M E van der Burg, F B Lammes, W L van Putten, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
July 4, 1997
Determination of the lactone and lactone plus carboxylate forms of 9-aminocamptothecin in human plasma by sensitive high-performance liquid chromatography with fluorescence detection
W J Loos, A Sparreboom, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma
A S Planting, R de Wit, M E van der Burg, et al.
Cancer Research
|
May 1, 1991
Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes
H J Lamers, J W Gratama, W L van Putten, et al.
British Journal of Haematology
|
October 1, 1994
High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia
H Burger, K Nooter, P Sonneveld, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1997
Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)
P H Hilkens, J Verweij, C J Vecht, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine
L C Pronk, A S Planting, R Oosterom, et al.
British Journal of Cancer
|
November 21, 1998
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients
R de Wit, W H Kruit, G Stoter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1992
Frequent administration of Dabis Maleate, a phase I study
J Verweij, A S Planting, M de Boer, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1996
The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary
A van der Gaast, J Verwij, A S Planting, et al.
Page
of 25